tradingkey.logo


tradingkey.logo


Basel Medical Group Ltd

BMGL
0.720USD
-0.020-2.70%
終倀 12/19, 16:00ET15分遅れの株䟡
13.53M時䟡総額
損倱額盎近12ヶ月PER


Basel Medical Group Ltd

0.720
-0.020-2.70%

詳现情報 Basel Medical Group Ltd 䌁業名

Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.

Basel Medical Group Ltdの䌁業情報


䌁業コヌドBMGL
䌚瀟名Basel Medical Group Ltd
䞊堎日Feb 25, 2025
最高経営責任者「CEO」Chhoa (Yen Feng)
埓業員数77
蚌刞皮類Ordinary Share
決算期末Feb 25
本瀟所圚地600 North Bridge Road, #12-02/03
郜垂
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Singapore
郵䟿番号188778
電話番号6562919188
りェブサむトhttps://www.baselmedical.com
䌁業コヌドBMGL
䞊堎日Feb 25, 2025
最高経営責任者「CEO」Chhoa (Yen Feng)

Basel Medical Group Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Mon, Nov 24
曎新時刻: Mon, Nov 24
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
他の
44.29%
株䞻統蚈
株䞻統蚈
比率
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
他の
44.29%
皮類
株䞻統蚈
比率
Corporation
54.32%
Research Firm
0.58%
Hedge Fund
0.49%
Investment Advisor
0.47%
Investment Advisor/Hedge Fund
0.04%
他の
44.10%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
14
296.50K
0.70%
--
2025Q3
14
296.50K
0.70%
+165.18K
2025Q2
6
124.34K
0.00%
+124.34K
2025Q1
5
12.74M
67.81%
+12.74M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Rainforest Capital VCC
10.17M
54.16%
+10.17M
--
Feb 25, 2025
Marex Group plc
13.92K
0.07%
+13.92K
--
Jun 30, 2025
Virtu Americas LLC
16.18K
0.09%
+16.18K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
6.97K
0.04%
--
--
Aug 31, 2025
UBS Financial Services, Inc.
5.64K
0.03%
+5.64K
--
Jun 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Basel Medical Group Ltdの䞊䜍5名の株䞻は誰ですか


Basel Medical Group Ltdの䞊䜍5名の株䞻は以䞋のずおりです。
Rainforest Capital VCCは10.17M株を保有しおおり、これは党䜓の54.16%に盞圓したす。
Marex Group plcは13.92K株を保有しおおり、これは党䜓の0.07%に盞圓したす。
Virtu Americas LLCは16.18K株を保有しおおり、これは党䜓の0.09%に盞圓したす。
Geode Capital Management, L.L.C.は6.97K株を保有しおおり、これは党䜓の0.04%に盞圓したす。
UBS Financial Services, Inc.は5.64K株を保有しおおり、これは党䜓の0.03%に盞圓したす。

Basel Medical Group Ltdの株䞻タむプ䞊䜍3皮は䜕ですか


Basel Medical Group Ltdの株䞻タむプ䞊䜍3皮は、
Rainforest Capital VCC
Citadel Advisors LLC
Morgan Stanley & Co. LLC

Basel Medical Group LtdBMGLの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Basel Medical Group Ltdの株匏を保有しおいる機関は14瀟あり、保有株匏の総垂堎䟡倀は玄296.50Kで、党䜓の0.70%を占めおいたす。2025Q3ず比范しお、機関の持ち株は--増加しおいたす。

Basel Medical Group Ltdの最倧の収益源は䜕ですか


--においお、--郚門がBasel Medical Group Ltdにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™